Luis
Muñoz Bellvís
Investigador hasta 2024
Hospital Universitario La Paz
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario La Paz (8)
2024
-
Repeated pancreatic resection for pancreatic metastases from renal cell Carcinoma: A Spanish multicenter study (PANMEKID)
Surgical Oncology, Vol. 52
-
Synergistic impact of innate immunity hyper-activation and endothelial dysfunction on the magnitude of organ failure in the infection-sepsis continuum
International Journal of Infectious Diseases, Vol. 146
2022
-
Pancreatic metastases from renal cell carcinoma. Postoperative outcome after surgical treatment in a Spanish multicenter study (PANMEKID)
European Journal of Surgical Oncology, Vol. 48, Núm. 1, pp. 133-141
2021
-
Impact of Bacillus Calmette-Gue´rin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection
BJS Open
-
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score
British Journal of Surgery, Vol. 19, Núm. 4
2020
-
Executive Summary of the Consensus Statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Tropical Medicine and International Health (SEMTSI), the Spanish Association of Surgeons (AEC), the Spanish Society of Pneumology and Thoracic Surgery (SEPAR), the Spanish Society of Thoracic Surgery (SECT), the Spanish Society of Vascular and Interventional Radiology (SERVEI), and the Spanish Society of Paediatric Infectious Diseases (SEIP), on the Management of Cystic Echinococcosis
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 6, pp. 283-288
2019
-
Multicentric study on total pancreatectomies
Cirugia Espanola, Vol. 97, Núm. 7, pp. 377-384
2012
-
No correlation between the expression of FXR and genes involved in multidrug resistance phenotype of primary liver tumors
Molecular Pharmaceutics, Vol. 9, Núm. 6, pp. 1693-1704